Skip to content
healthcare.dev

KEBILIDI

NDC 52856-601, eladocagene exuparvovec-tneq, suspension, from PTC Therapeutics, Inc..

Product NDC
52856-601
Status
Listed
Labeler
PTC Therapeutics, Inc.
Dosage form
SUSPENSION
Route
INTRACEREBRAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125722
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52856-601 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ELADOCAGENE EXUPARVOVEC560000000000 {GC}/mL
Package NDCNDC-11Package
52856-601-01528560601011 VIAL, GLASS in 1 CARTON (52856-601-01) / .5 mL in 1 VIAL, GLASS (52856-601-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9d6a6401-c6b5-4f29-af11-67707d249482

Use it

Look up 52856-601 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52856-601 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52856-601. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.